GlassScriptPhysician profile
Megan M Krom
NPI 1124773171
$2,156.93
in general payments reported to CMS, 2019-2025
14 companies · $256 in 2025
The $256 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $263 · 2023: $979 · 2024: $659 · 2025: $256.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,148 · Travel and Lodging: $745.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,148.37 |
| Travel and Lodging | $745.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $813.65 | 2023-2025 | Interstim |
| Corium, LLC | $465.41 | 2022-2025 | Azstarys |
| Teleflex LLC | $197.31 | 2024-2025 | Urolift, Barrigel |
| Supernus Pharmaceuticals, INC. | $134.37 | 2022-2023 | Qelbree |
| Sanofi Pasteur INC. | $122.79 | 2022-2023 | |
| 180 Medical, INC. | $95.95 | 2024-2025 | Rusch |
| Procept Biorobotics Corporation | $64.34 | 2024-2025 | Aquabeam System |
| Sumitomo Pharma America, INC. | $60.27 | 2024 | Gemtesa |
| Pfizer INC. | $58.46 | 2022-2024 | |
| Urogen Pharma, INC. | $51.33 | 2025 | |
| Glaxosmithkline, LLC. | $32.29 | 2022-2023 | Pediarix, Bexsero |
| Laborie Medical Technologies Corp. | $22.99 | 2025 | |
| Boston Scientific Corporation | $18.90 | 2025 | Axonics |
| Tris Pharma INC | $18.87 | 2023 | Dyanavel Xr |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Megan Krom listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.